ProNAi Therapeutics (DNAI) Misses Q2 EPS by 5c

August 12, 2016 7:27 AM EDT
Get Alerts DNAI Hot Sheet
Trade DNAI Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

ProNAi Therapeutics (NASDAQ: DNAI) reported Q2 EPS of ($0.43), $0.05 worse than the analyst estimate of ($0.38).

At June 30, 2016, ProNAi had $130.6 million in cash and cash equivalents compared to $150.2 million in cash and cash equivalents at December 31, 2015.

For earnings history and earnings-related data on ProNAi Therapeutics (DNAI) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment